Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPTIFIBATIDE for Antiplatelet therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 60 adverse event reports in the FDA FAERS database where EPTIFIBATIDE was used for Antiplatelet therapy.

Most Reported Side Effects for EPTIFIBATIDE

Side Effect Reports % Deaths Hosp.
Product use in unapproved indication 61 13.2% 0 1
Thrombocytopenia 58 12.6% 0 24
Drug ineffective 39 8.4% 9 22
Off label use 31 6.7% 1 4
Haemoglobin decreased 30 6.5% 3 15
Haemorrhage 28 6.1% 5 7
Vascular stent thrombosis 19 4.1% 0 16
Condition aggravated 14 3.0% 7 10
Gastrointestinal haemorrhage 14 3.0% 1 9
Haematoma 14 3.0% 4 9
Product use issue 14 3.0% 1 2
Hypotension 13 2.8% 6 8
Pulmonary alveolar haemorrhage 13 2.8% 6 7
Subarachnoid haemorrhage 13 2.8% 3 7
Haemoptysis 12 2.6% 2 7

Other Indications for EPTIFIBATIDE

Product used for unknown indication (57) Acute myocardial infarction (36) Cerebral artery occlusion (29) Thrombosis (26) Coronary artery thrombosis (18) Percutaneous coronary intervention (17) Myocardial infarction (13) Acute coronary syndrome (12) Thrombosis in device (12) Ischaemic stroke (11)

Other Drugs Used for Antiplatelet therapy

CLOPIDOGREL BISULFATE (3,520) ASPIRIN (3,410) TIROFIBAN (1,513) TICAGRELOR (660) PRASUGREL (235) HEPARIN (96) ASPIRIN DL-LYSINE (59) WARFARIN (59) CILOSTAZOL (53) CANGRELOR (41)

Related Pages

EPTIFIBATIDE Full Profile All Antiplatelet therapy Drugs EPTIFIBATIDE Demographics EPTIFIBATIDE Timeline